Eric Westin

Member of Scientific Advisory Board at Exacis Biotherapeutics

Dr. Westin lead the antimitotic group and was promoted to Vice President & Head of Early Clinical Research and Development in the Oncology Therapeutic Area Unit. As the lead for that group he worked closely with both research and business development to help refine strategy for the shift in portfolio biology toward targeted therapy and immuno-oncology. In 2017, Dr. Westin joined ImmunoGen and is currently Vice President of Clinical Development and Translational Sciences.

Org chart

Gregory Fiore

Co-founder, President and CEO

Caron Jacobson

Scientific Advisor

Pamela Munster

Scientific Advisor

Evren Alici

Scientific Advisor

Matt Angel

Scientific Co-Founder, Chair of Scientific Advisory Board

Gunnar Kaufmann

Member of Scientific Advisory Board

Mark Corrigan

Chair of Exacis Board of Directors

Christopher Rohde

Member of Scientific Advisory Board

Teams

+3

Board of Directors

6 members

Timeline

  • Member of Scientific Advisory Board

    Current role